Multi-task neural networks improve prediction of blood metabolite profiles from genetic and clinical data
Researchers developed a multi-task neural network (NN) architecture to predict circulating metabolite profiles using genetic and covariate data, achieving the highest mean predictive performance (R²=0.219) compared to simpler models. The study used a three-stage design separating covariate, genotype, and combined contributions, finding that performance gains came primarily from nonlinear covariate modelling rather than genetic factors. The findings suggest deep learning could improve metabolome prediction for research and clinical applications, though further validation is needed.
A preprint posted to bioRxiv describes a multi-task neural network designed to predict blood metabolite profiles by jointly modelling covariates, genotype data, and their interactions through a three-stage architecture. In head-to-head comparisons, the multi-task NN achieved the best mean R² of 0.219 across metabolites, edging out a single-task NN (R²=0.211), elastic net regression (R²=0.207), and an activation-free multi-task model (R²=0.191). Decomposition analyses revealed that the performance advantage was driven largely by the model's capacity to capture nonlinear covariate effects, while genetic and joint covariate-genotype contributions were limited and varied across metabolites. Circulating metabolites are known to reflect clinically relevant physiological states and have been implicated in disease aetiology, yet they are more commonly studied as biomarkers than as prediction targets. The authors argue that with further validation, such compact multi-task NNs could serve as practical tools for metabolite profile prediction in both research and clinical contexts.
What's missing
As a preprint, this work has not yet undergone peer review. The modest absolute R² values across models raise open questions about clinical utility thresholds. The authors acknowledge that genetic and joint contributions were limited and heterogeneous, but do not fully explore whether larger or more diverse cohorts might change this picture.
What different sources said
- bioRxivCenter
Covariate-aware genomic prediction of blood metabolite profiles using multi-task neural networks
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.